Zydus Cadila gets USFDA nod to market generic drug to treat tapeworm infections; to manufacture product at Gujarat plant
The product will be manufactured at Zydus Cadilla's plant at Moraiya, Ahmedabad
New Delhi: Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Albendazole Tablets, used in treating certain tapeworm infections, in the American market.
The company has received the final approval from the US Food and Drug Administration (USFDA) to market Albendazole Tablets USP in strength of 200 mg, Zydus Cadila said in a statement.
The company's product will be manufactured at Zydus group’s formulations manufacturing facility at Ahmedabad. It also received tentative approval from the USFDA for Pregabalin capsules, used to help control certain kinds of seizures, in multiple strengths ranging from 25 mg to 300 mg.
The product will be manufactured at its plant at Moraiya, Ahmedabad.
Zydus group now has 239 approvals from the USFDA and has so far filed over 340 abbreviated new drug applications (ANDAs) since the commencement of the its filing process in 2003-04.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
Drug firm Zydus Cadila Thursday said it has received tentative nod from the US health regulator to market generic Sitagliptin and Metformin Hydrochloride extended-release tablets used for controlling blood sugar levels
The drug Risedronate Sodium delayed-release tablets, used for the treatment of osteoporosis in post-menopausal women.
Here's a round up of some of the deals announced recently.